Varian and Medison America sign marketing deal:
This article was originally published in Clinica
Varian Oncology Systems and Medison America, together with its Cone/Medison joint venture, are to jointly market products for use in radiation oncology, urology and gynaecology. Products covered include: Varian's VariSource high dose rate brachytherapy system; Medison America's Voluson 530D 3D ultrasound system; and Cone/Medison's Combison 301 ultrasound system. The companies aim to increase co-operation in prostate brachytherapy using 3D ultrasound. They will also focus R&D efforts on new applications of 3D ultrasound technology for cancer and other disorders. Varian is based in Palo Alto, Medison in Pleasanton, California, and Cone Medison is located in Solon, Ohio.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.